Month: April 2023

news_6

Bone Biologics Receives Human Research Ethics Committee Approval to Begin Pilot Clinical Trial with NB1 in Spinal Fusion Patients in Australia

Company plans to begin 30-patient trial later this year BURLINGTON, Mass.--(BUSINESS WIRE)--Bone Biologics Corporation (NASDAQ: BBLG), a developer of orthobiologic...

logo-19

Asia-Pacific Real-Time Payment Market Report 2023: Real-Time Payments Gradually Gaining Popularity as a Preferred Payment Method – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Asia-Pacific Real-Time Payment Market 2023" report has been added to ResearchAndMarkets.com's offering. Real-time payments gradually gaining popularity as...

GENEXINE_CI

Genexine’s Long-acting Anemia Treatment GX-E4 Phase 3 Clinical Trial Interim Result Is Presented at WCN2023, Confirmed Non-inferiority Compared to Mircera

SEOUL, South Korea--(BUSINESS WIRE)--A clinical-staged proprietary platform technology biotech company Genexine (KQ 095700, CEO Neil Warma) and its Asian regional...